Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

CANADA: Canadian Researchers' Device May Improve HIV Tracking


Ottawa Citizen (12.13.11) - Friday, December 16, 2011

Canadian researchers are hoping to bring a small, cheap blood cell analyzer to HIV patients living in the developing world. The on-the-spot HIV blood testing device can monitor whether the disease has progressed, and it can be used outside the lab by a trained nurse, according to the team.

"There are tons of stories out there with people that walk half a day to a clinic to get blood [drawn], and that sample gets taken by bicycle or by truck to a bigger urban center," said team leader Rakesh Nayyar of the University of Toronto's University Health Network. "And then they've got hundreds of tests, so they don't get to the tests for days. You don't get results [because] to disseminate the data takes a long time." Most machines currently performing flow cytometry are larger than a microwave and smaller than a dishwasher, said James Dou, a University of Toronto student who also is working on the device with his research adviser, Stewart Aitchison.

The first prototype is about the size of a loaf of bread. However, the device is being downsized to a little larger than a smartphone, with similar capabilities, such as a camera, GPS and wireless communication. The team also is working on database linkage to enable doctors to keep track of patients in remote areas, Dou said.

The cost per device will be about $5,000-$10,000 (US $4,800- $9,600), and each test will cost only a few dollars to process. By March, the team hopes to have up to 100 units ready for field testing in Malawi and Thailand.


Copyright © 2011 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

Information in this article was accurate in December 16, 2011. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.